156 related articles for article (PubMed ID: 37550584)
21. Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers.
Davis IJ; Kim JJ; Ozsolak F; Widlund HR; Rozenblatt-Rosen O; Granter SR; Du J; Fletcher JA; Denny CT; Lessnick SL; Linehan WM; Kung AL; Fisher DE
Cancer Cell; 2006 Jun; 9(6):473-84. PubMed ID: 16766266
[TBL] [Abstract][Full Text] [Related]
22. Clear Cell Tumor With Melanocytic Differentiation and ACTIN-MITF Translocation: Report of 7 Cases of a Novel Entity.
de la Fouchardiere A; Pissaloux D; Tirode F; Karanian M; Fletcher CDM; Hanna J
Am J Surg Pathol; 2021 Jul; 45(7):962-968. PubMed ID: 33264137
[TBL] [Abstract][Full Text] [Related]
23. MUM-1 expression differentiates tumors in the PEComa family from clear cell sarcoma and melanoma.
Ferenczi K; Lastra RR; Farkas T; Elenitsas R; Xu X; Roberts S; Brooks JS; Zhang PJ
Int J Surg Pathol; 2012 Feb; 20(1):29-36. PubMed ID: 21903680
[TBL] [Abstract][Full Text] [Related]
24. Expanding the Phenotypic Spectrum of Mesenchymal Tumors Harboring the EWSR1-CREM Fusion.
Yoshida A; Wakai S; Ryo E; Miyata K; Miyazawa M; Yoshida KI; Motoi T; Ogawa C; Iwata S; Kobayashi E; Watanabe SI; Kawai A; Mori T
Am J Surg Pathol; 2019 Dec; 43(12):1622-1630. PubMed ID: 31305268
[TBL] [Abstract][Full Text] [Related]
25. Compound clear cell sarcoma with EWSR1::CREM fusion.
Li P; Busam K
J Cutan Pathol; 2023 Dec; 50(12):1065-1069. PubMed ID: 36640048
[TBL] [Abstract][Full Text] [Related]
26. The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma.
Li KK; Goodall J; Goding CR; Liao SK; Wang CH; Lin YC; Hiraga H; Nojima T; Nagashima K; Schaefer KL; Lee KA
Br J Cancer; 2003 Sep; 89(6):1072-8. PubMed ID: 12966428
[TBL] [Abstract][Full Text] [Related]
27. Primary Clear Cell Sarcoma of Bone: Clinicopathologic Study of a Rare Presentation.
Odintsov I; Jagannathan JP; Al-Ibraheemi A; Selig MK; Newman ET; Fletcher CDM; Nielsen GP; Hornick JL
Am J Surg Pathol; 2023 Mar; 47(3):354-360. PubMed ID: 36730915
[TBL] [Abstract][Full Text] [Related]
28. Quantitative comparison of MiTF, Melan-A, HMB-45 and Mel-5 in solar lentigines and melanoma in situ.
Kim J; Taube JM; McCalmont TH; Glusac EJ
J Cutan Pathol; 2011 Oct; 38(10):775-9. PubMed ID: 21797920
[TBL] [Abstract][Full Text] [Related]
29. A case report of cutaneous melanocytoma with CRTC1-TRIM11 fusion: Is CMCT distinct from clear cell sarcoma of soft tissue?
Kashima J; Motoi T; Nishimaki M; Hayashi Y; Ogawa M; Kato I; Yamada R; Tonooka A; Horiguchi SI; Funata N; Hishima T; Yoshino K
Pathol Int; 2019 Aug; 69(8):496-501. PubMed ID: 31276279
[TBL] [Abstract][Full Text] [Related]
30. Primary intra-abdominal melanoma arising in association with extracutaneous blue naevus: a report of two cases.
Shah K; Folpe AL; Miller M; Morgan JA; Raut CP; Doyle LA
Histopathology; 2021 Jan; 78(2):281-289. PubMed ID: 32698251
[TBL] [Abstract][Full Text] [Related]
31. MITF accurately highlights epidermal melanocytes in atypical intraepidermal melanocytic proliferations.
Nybakken GE; Sargen M; Abraham R; Zhang PJ; Ming M; Xu X
Am J Dermatopathol; 2013 Feb; 35(1):25-9. PubMed ID: 22668579
[TBL] [Abstract][Full Text] [Related]
32. Primary Clear Cell Sarcoma of the Ileum: A Case Report With Next-Generation Sequencing Analysis.
Zhu P; Zhang T; Bi K; Wu Y; Chen X; Zhang H; Huang D; Zhang L; Zeng Y; Yi X
Int J Surg Pathol; 2021 Sep; 29(6):677-684. PubMed ID: 33412984
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases.
Buonaccorsi JN; Prieto VG; Torres-Cabala C; Suster S; Plaza JA
Am J Dermatopathol; 2014 Feb; 36(2):124-30. PubMed ID: 23782678
[TBL] [Abstract][Full Text] [Related]
34. Melanocytic differentiation is present in a significant proportion of nonpigmented diffuse neurofibromas: a potential diagnostic pitfall.
Pižem J; Nicholson KM; Mraz J; Prieto VG
Am J Surg Pathol; 2013 Aug; 37(8):1182-91. PubMed ID: 23715161
[TBL] [Abstract][Full Text] [Related]
35. Microphthalmia-associated transcription factor (MiTF): Promiscuous staining patterns in fibrohistiocytic lesions is a potential pitfall.
Mohanty SK; Sharma S; Pradhan D; Kandukuri SR; Farahani N; Barry C; Wu JM; Frishberg D; Balzer B
Pathol Res Pract; 2018 Jun; 214(6):821-825. PubMed ID: 29773427
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous clear cell myomelanocytic tumour: a new member of the growing family of perivascular epithelioid cell tumours (PEComas). Clinicopathological and immunohistochemical analysis of seven cases.
Mentzel T; Reisshauer S; Rütten A; Hantschke M; Soares de Almeida LM; Kutzner H
Histopathology; 2005 May; 46(5):498-504. PubMed ID: 15842631
[TBL] [Abstract][Full Text] [Related]
37. Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.
Xu X; Chu AY; Pasha TL; Elder DE; Zhang PJ
Am J Surg Pathol; 2002 Jan; 26(1):82-7. PubMed ID: 11756773
[TBL] [Abstract][Full Text] [Related]
38. Cathepsin K in the immunohistochemical diagnosis of melanocytic lesions.
Rao Q; Wang Y; Xia QY; Shi SS; Shen Q; Tu P; Shi QL; Zhou XJ; Wu B
Int J Clin Exp Pathol; 2014; 7(3):1132-9. PubMed ID: 24696729
[TBL] [Abstract][Full Text] [Related]
39. Primary cutaneous PEComa: distinctive clear cell lesions of skin.
Liegl B; Hornick JL; Fletcher CD
Am J Surg Pathol; 2008 Apr; 32(4):608-14. PubMed ID: 18277881
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion: a case report.
Duan R; He X; Ma X; Huang F; Hu X
Diagn Pathol; 2024 Jan; 19(1):8. PubMed ID: 38184586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
